Devazepide from MedChemExpress

Product Specs
ItemDevazepide
CompanyMedChemExpress
Price $165.00Supplier Page View Company Product Page
Catalog NumberHY-106301
Quantity10 mM * 1 mL
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.55%
TypeChemical
Molecular Weight408.45
FormulaC₂₅H₂₀N₄O₂
Research AreaMetabolic Disease

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Cholecystokinin A Receptor Knockdown Diminishes Colon Cancer Cell Invasive Potential via Modulation of Integrin/FAK, EMT, and uPA/uPAR/MMP2 AxisOncology ResearchMarch 23, 2026Chun-Shiang Lin, Ta-Wen Hsu, Hsiang-Lin Lee, Shao-Hsuan Kaoobtained from Sigma-Aldrich (St. Louis, MO, USA). Devazepide, CCKAR antagonist, was purchased from (HY-106301, MedChemExpress, New York, NY, USA). For Western blotting, antibodies specificically recognized human

(2) Gut-to-brain signaling restricts dietary protein intake during recovery from catabolic statesCellDecember 24, 2025Nikolai P. Jaschke, Joseph R. Luchsinger, Zuojia Chen, Vera C. Wulfmeyer, Xavier de la Rosa, Oliver Hahn, Cuiling Zhang, Nathaniel D. Bachtel, Jaime L. Cullen, Tilman D. Rachner, et al.M1547 D-mannitol,Sigma-Aldrich,Cat#M4125 methionine-DL-sulfoximine,Medchemexpress,Cat#HY-B1692 ondansetron,Sigma-Aldrich,Cat#O3639 clozapine-n-oxide,Fisher Scientific,Cat#A3317–50 GsMTx4,Tocris,Cat# 4912 devazepide,Medchemexpress,Cat#HY-106301 MK0893,Medchemexpress,Cat#HY-50663 resiniferatoxin (RTX),Alomone Labs,Cat#R-400 fenclonine,Medchemexpress,Cat#HY-B1368 ally

(3) LRG1 inhibition promotes acute pancreatitis recovery by inducing cholecystokinin Type 1 receptor expression via AktTheranosticsMarch 18, 2025Seok Ting Lim, Xinmei Zhao, Shuqing Liu, Wenjuan Zhang, Yuanyang Tan, Nidula Mullappilly, Sandip M Swain, Mei Ling Leong, Ravisankar Rajarethinam, Kah Fei Wan, et al.by CO2 asphyxiation. CCK1R antagonist and LRG1 neutralizing antibody treatment in-vivo L364, 718 (#HY-106301, MedChemExpress, USA), a competitive non-peptide antagonist of CCK1R was administered intraperitoneally

(4) The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in miceEuropean journal of clinical investigationFebruary 1, 2016Wang HH, Portincasa P, Wang DQ.

(5) Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mousePsychopharmacologyJanuary 1, 1991Vasar E, Harro J, Lang A, Pôld A, Soosaar A.

(6) Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonistProceedings of the National Academy of Sciences of the United States of AmericaJuly 1, 1986Chang RS, Lotti VJ.

(7) Scanning esophageal impedance probe for measurement of luminal cross sectionThe American journal of physiologyMay 1, 1979Mary DA, North PJ, Hunt JN.

Be the First to Write a Review!

Devazepide from MedChemExpress

Description

MedChemExpress

Citations (7)

Reviews

Devazepide from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map